Clinical Trial Update: Atomoxetine, Placebo and Parent Management Training in Autism [Phase 4]

View source ↗

Summary

Phase 4 study evaluating atomoxetine versus placebo in combination with parent management training for children with autism and related pervasive developmental …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asperger Syndrome
• Attention Deficit Hyperactivity Disorder
• Autism Spectrum Disorder
• Pervasive Developmental Disorder

Drugs mentioned

• Atomoxetine (Atomoxetine)

Snippet

Sponsor: University of Rochester | Conditions: Autism, Pervasive Development Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-02-04